Carcinoma in Situ

22 registered clinical trials studyying Carcinoma in Situ — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) NCT06833073	Merck Sharp & Dohme LLC	Phase 2
Active Not Recruiting	Role of MRI Breast in Detection of Ductal Carcinoma in Situ NCT06744140	Superior University	—
Recruiting	A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in NCT06022029	OncoNano Medicine, Inc.	Phase 1
Completed	Handheld Ultrasound Device to Triage Women With a Positive Clinical Breast Examination by Trained Non-radiolog NCT06056843	International Agency for Research on Cancer	N/A
Terminated	A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer ( NCT05014139	Astellas Pharma Global Development, Inc.	Phase 1
Completed	Evaluation of in Vitro Devices on Self-collected Vaginal Swab and Urine Sample for Testing of Human Papilloma NCT04312737	Hiantis Srl	—
Withdrawn	PDT Plus Vitamin D3 for Anal Dysplasia NCT02698293	Abramson Cancer Center at Penn Medicine	Phase 1
Completed	Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices NCT03808818	ECOG-ACRIN Cancer Research Group	N/A
Completed	Early Detection of High Grade Ovarian Cancer Using Uterine Lavage EHUD Study and Duplex Sequencing NCT04823871	Paul Speiser, Prof.MD,	N/A
Completed	Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and N NCT03268993	University of Pittsburgh	N/A
Active Not Recruiting	Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer NCT03223753	Children's Oncology Group	Phase 3
Completed	Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell NCT03182959	University of Arizona	EARLY_Phase 1
Completed	E7 TCR T Cells for Human Papillomavirus-Associated Cancers NCT02858310	National Cancer Institute (NCI)	Phase 1 / Phase 2
Recruiting	Project: Every Child for Younger Patients With Cancer NCT02402244	Children's Oncology Group	—
Terminated	Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer NCT01438112	CG Oncology, Inc.	Phase 2 / Phase 3
Completed	Localization of Nonpalpable Breast Lesions NCT01901991	Rigshospitalet, Denmark	N/A
Completed	Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial Carcinoma NCT02039388	Medical University of Vienna	N/A
Completed	Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer NCT01731652	Telormedix SA	Phase 2
Completed	Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesio NCT02217358	University Hospital Ostrava	N/A
Terminated	Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Mainte NCT01310803	Endo Pharmaceuticals	Phase 3
Terminated	Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomyci NCT01200992	Bioniche Life Sciences Inc.	Phase 3
Completed	Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Hav NCT01316874	Endo Pharmaceuticals	Phase 2 / Phase 3